PharmaSGP Holding SE

FSX:PSG.DE

24 (EUR) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2023202220212020201920182017
Operating Activities:
Net Income 16.39711.95410.6910.6416.70614.73311.783
Depreciation & Amortization 9.2969.253.5730.4860.3970.3870.411
Deferred Income Tax 0.0750.1940.056-0.0040.110.181-0.072
Stock Based Compensation -0.0470.1040.0210000
Change In Working Capital -5.1071.148-3.6799.122-3.132-4.2243.377
Accounts Receivables -1.39-1.2192.8891.417-3.111-1.7890.404
Inventory -3.115-2.817-1.149-0.941.17200
Accounts Payables 1.034.461-5.478.8973.11100
Other Working Capital -1.6320.7230.051-0.252-4.304-4.2243.377
Other Non Cash Items 24.0552.3611.656-4.793.66-1.881-0.44
Operating Cash Flow 22.64924.71312.2415.45817.6318.42214.237
Investing Activities:
Investments In Property Plant And Equipment -0.866-0.787-83.459-0.898-0.433-0.274-0.397
Acquisitions Net 00000.1090.0590.482
Purchases Of Investments 0000000
Sales Maturities Of Investments 0000000
Other Investing Activites -0.813-0.667-83.365-0.478-0.3240.0590.482
Investing Cash Flow -0.866-0.787-83.459-0.898-0.324-0.2150.085
Financing Activities:
Debt Repayment -8.054-4.485-85-0.247-0.264-0.253-0.258
Common Stock Issued 0000.120011.541
Common Stock Repurchased -0.2860000-4.0490
Dividends Paid -5.875-5.40-94.833-5.500
Other Financing Activities 0.996-2.223169.042-0.322-0.339-4.05511.527
Financing Cash Flow -13.659-12.10884.042-95.035-5.839-4.30211.283
Other Information:
Effect Of Forex Changes On Cash 0000000
Net Change In Cash 8.12411.81812.823-80.47511.4683.90525.605
Cash At End Of Period 40.76632.64220.8248.00188.47677.00873.103